These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia]. Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F. G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937 [Abstract] [Full Text] [Related]
26. [Electrophysiologic study of propafenon in Wolff-Parkinson-White syndrome]. Clémenty J, Sourdille N, Pedeboscq G, Bricaud H. Ann Cardiol Angeiol (Paris); 1982 Apr; 31(5):351-5. PubMed ID: 7158983 [No Abstract] [Full Text] [Related]
28. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)]. Laimer H, Glogar D, Zilcher H. Acta Med Austriaca; 1981 Apr; 8(5):140-4. PubMed ID: 7331741 [Abstract] [Full Text] [Related]
29. [Propafenon, a new anti-arrhythmic drug (author's transl)]. Aldor E, Heeger H. Dtsch Med Wochenschr; 1976 Sep 03; 101(36):1318-22. PubMed ID: 60209 [Abstract] [Full Text] [Related]
32. Clinical applications of antiarrhythmic drugs. Lavenne F, de Jonghe D. Acta Cardiol Suppl; 1980 Sep 03; (25):27-42. PubMed ID: 6155012 [No Abstract] [Full Text] [Related]
33. [Retardation of the excitation conduction by propaphenone. Duration and dosage effect relation after oral administration (author's transl)]. Beck OA, Abdulla S, Hochrein H. MMW Munch Med Wochenschr; 1975 Aug 29; 117(35):1369-72. PubMed ID: 809677 [Abstract] [Full Text] [Related]
34. [The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) (author's transl)]. Beck OA, Vogt J, Hochrein H. Z Kardiol; 1978 Jan 29; 67(1):41-5. PubMed ID: 629072 [Abstract] [Full Text] [Related]
35. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. Klempt HW, Nayebagha A, Fabry E. Z Kardiol; 1982 May 29; 71(5):340-9. PubMed ID: 6180562 [Abstract] [Full Text] [Related]
36. Propafenone for the treatment of severe ventricular arrhythmias. Rabkin SW, Rotem CE, Boroomand-Rashti K, Bar-Shlomo B. Can Med Assoc J; 1984 Sep 15; 131(6):601-3. PubMed ID: 6478345 [Abstract] [Full Text] [Related]
37. [Holter analysis of ventricular arrhythmias and its treatment with propafenone]. Peralta Heredia R. Arch Inst Cardiol Mex; 1986 Sep 15; 56(3):225-30. PubMed ID: 2428317 [Abstract] [Full Text] [Related]
38. [Electrophysiologic effects of propafenone in subjects with pre-existing excito-conduction disorders]. Rizzo A, Fiorilli R, Lisanti P. G Ital Cardiol; 1984 May 15; 14(5):377-8. PubMed ID: 6468820 [Abstract] [Full Text] [Related]
39. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF. Arch Mal Coeur Vaiss; 1985 Oct 15; 78 Spec No():81-90. PubMed ID: 3938264 [Abstract] [Full Text] [Related]
40. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. Manz M, Beermann J, Gerckens U, Lüderitz B. Z Kardiol; 1986 Dec 15; 75(12):757-63. PubMed ID: 3825226 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]